VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205 | -10.5% | 7,600 | 0.0% | 0.03% | -8.6% |
| Q2 2023 | $229 | -99.9% | 7,600 | 0.0% | 0.04% | -12.5% |
| Q1 2023 | $245,860 | +12.9% | 7,600 | 0.0% | 0.04% | +2.6% |
| Q4 2022 | $217,816 | +4.7% | 7,600 | 0.0% | 0.04% | -7.1% |
| Q2 2022 | $208,000 | -28.5% | 7,600 | 0.0% | 0.04% | -20.8% |
| Q1 2022 | $291,000 | -5.2% | 7,600 | -20.8% | 0.05% | -5.4% |
| Q4 2021 | $307,000 | +8.5% | 9,600 | 0.0% | 0.06% | 0.0% |
| Q3 2021 | $283,000 | -13.2% | 9,600 | 0.0% | 0.06% | -13.8% |
| Q2 2021 | $326,000 | +4.5% | 9,600 | 0.0% | 0.06% | -1.5% |
| Q1 2021 | $312,000 | -9.8% | 9,600 | 0.0% | 0.07% | -18.5% |
| Q4 2020 | $346,000 | -14.1% | 9,600 | -6.8% | 0.08% | -27.0% |
| Q3 2020 | $403,000 | +6.6% | 10,300 | 0.0% | 0.11% | +3.7% |
| Q2 2020 | $378,000 | +42.1% | 10,300 | -10.8% | 0.11% | +21.6% |
| Q1 2020 | $266,000 | -21.3% | 11,550 | 0.0% | 0.09% | +3.5% |
| Q4 2019 | $338,000 | +4.6% | 11,550 | -4.5% | 0.08% | -3.4% |
| Q3 2019 | $323,000 | -11.7% | 12,100 | -15.4% | 0.09% | -11.1% |
| Q2 2019 | $366,000 | +0.3% | 14,300 | -12.3% | 0.10% | -2.9% |
| Q1 2019 | $365,000 | -11.4% | 16,300 | -16.6% | 0.10% | -22.7% |
| Q4 2018 | $412,000 | +12.0% | 19,550 | -1.5% | 0.13% | +33.3% |
| Q3 2018 | $368,000 | -21.5% | 19,850 | -5.5% | 0.10% | -26.1% |
| Q2 2018 | $469,000 | +1.5% | 21,000 | 0.0% | 0.13% | +0.8% |
| Q1 2018 | $462,000 | -13.6% | 21,000 | -8.7% | 0.13% | -13.1% |
| Q4 2017 | $535,000 | -0.9% | 23,000 | -2.1% | 0.15% | +0.7% |
| Q3 2017 | $540,000 | -33.6% | 23,500 | -36.1% | 0.15% | -31.8% |
| Q2 2017 | $813,000 | -23.5% | 36,800 | -21.0% | 0.22% | -26.2% |
| Q1 2017 | $1,063,000 | +9.0% | 46,600 | 0.0% | 0.30% | +3.1% |
| Q4 2016 | $975,000 | -21.7% | 46,600 | -1.1% | 0.29% | -29.7% |
| Q3 2016 | $1,245,000 | -10.9% | 47,100 | -6.5% | 0.42% | -10.3% |
| Q2 2016 | $1,397,000 | – | 50,400 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |